Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3 Thoracic 1

Conditions

Lung Neoplasms 8 Motor Activity 3 Thyroid Neoplasms 1 Spinal Stenosis 1 Prostatic Neoplasms 1 Pneumothorax 1 Pleural Neoplasms 1 Pathologic Processes 1 Parathyroid Neoplasms 1 Ovarian Neoplasms 1 Mesothelioma 1 Lymphatic Metastasis 1 Intervertebral Disc Displacement 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Docetaxel 19 pembrolizumab 14 Surveys and Questionnaires 7 Radiotherapy 7 Paclitaxel 7 Magnetic Resonance Spectroscopy 7 Gemcitabine 7 Standard of Care 6 Specimen Handling 6 Radiosurgery 6 Psychiatric Rehabilitation 6 Early Intervention, Educational 6 Trastuzumab 5 Nivolumab 5 enzalutamide 4 Interviews as Topic 4 motexafin gadolinium 3 cabozantinib 3 X-Rays 3 Sirolimus 3 Methods 3 Educational Status 3 Cisplatin 3 Carboplatin 3 Azacitidine 3 tisotumab vedotin 2 rucaparib 2 pertuzumab 2 pegilodecakin 2 palbociclib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × Control Groups × Thoracic × Clear all

NCT05319145 2022-04-13

PROFIT

Hospital Universitari Vall d'Hebron Research Institute

Phase NA Unknown

GenitourinaryThoracic

Lung Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡